Establishment of treatment method for intrauterine microbiota

Examination of therapeutic effects of intrauterine microbiota by antibiotics, Probiotics and Prebiotics - Examination of therapeutic effects of intrauterine microbiota by antibiotics, Probiotics and Prebiotics

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038582

Enrollment

Registered

2019-11-14

Start date

2019-11-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine microbiota abnormalities

Interventions

Probiotics(oral medicine 3g/day)30days Prebiotics(oral medicine 300mg/day)30days antibiotics(oral medicine 750mg/day)7days antibiotics(Vaginal tablet 250mg)1 time Probiotics(oral medicine 3g/day)30d

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Repeated implantation failure Less than 90% of Lactobacillus or Bifidobacterium in the uterine microbiota

Exclusion criteria

Exclusion criteria: History of uterine surgery

Design outcomes

Primary

Measure	Time frame
Percentage of Lactobacillus and Bifidobacterium in Intrauterine microbiota	—

Countries

Japan

Contacts

Public ContactDAISUKE KADOGAMI

IVF Namba Clinic Doctor

kadogami515@ivfjapan.com0665348824

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026